Piperazine-Containing Azamacrocyclic Fluorophores
Exp er im en ta l Section
4-(4-{4-[4-(4-ter t-Bu tylca r boxy-p ip er a zin -1-yl)-bu toxy]-
p h en oxy}-bu tyl)-p ip er a zin e-1-ca r boxylic Acid ter t-Bu tyl
Ester (2). A mixture of 1 (1.26 g, 5.03 mmol), mono-Boc-
piperazine (1.90 g, 10.20 mmol), and Ti(O-iPr)4 (3.59 g, 12.63
mmol) was stirred at room temperature. After 1 h, the viscous
solution was diluted with 10 mL of absolute EtOH. NaBH3CN
(423 mg, 6.73 mmol) was added, and the solution was stirred
for 20 h. Water (10 mL) was added with stirring, and the
resulting inorganic precipitate was filtered and washed with
EtOH. The solvent was removed with a rotary evaporator, and
the residue was purified by column chromatography (silica gel,
CH2Cl2/MeOH 95:5) to give 2.40 g (81%) of 2 as a colorless,
viscous oil. 1H NMR (400 MHz, CDCl3): δ 6.73 (s, 4H), 3.85
(t, J ) 6.3 Hz, 4H), 3.38 (t, J ) 4.8 Hz, 8H), 2.38-2.35 (m,
12H), 1.75-1.68 (m, 4H), 1.65-1.59 (m, 4H), 1.39 (s, 18H). 13
NMR (100 MHz, CDCl3): δ 154.6, 153.0, 115.3, 79.6, 68.1, 58.1,
C
52.9, 28.3, 27.2, 23.1. HRMS-FAB for
C32H54N4O6: calc
591.4122 [M + H]+, found 591.4125.
1-{4-[4-(4-P iper azin e-1-yl-bu toxy)-ph en oxy]-bu tyl}-pip-
er a zin e (3). TFA (5 mL) was added to a solution of 2 (1.95 g,
3.30 mmol) in CH2Cl2 (15 mL). The mixture was stirred at
room temperature for 30 min. After 30 min, the solvent was
removed with a rotary evaporator, and 30 mL of 1 N NaOH
was added to the residue. The aqueous layer was extracted
with CH2Cl2 (3 × 50 mL), and the organic phase was washed
with brine and dried over MgSO4. The solvent was removed
1
in vacuo to give 1.23 g (95%) of 3 as a colorless viscous oil. H
F IGURE 5. 13C NMR spectra before (bottom) and after (top)
addition of 2 equiv of Zn2+ to 9 and assignment of resonances
in compound 9. Solvent: CD3CN/CDCl3 (9:1).
NMR (400 MHz, CDCl3): δ 6.73 (s, 4H), 3.84 (t, J ) 6.3 Hz,
4H), 2.82 (t, J ) 4.8 Hz, 8H), 2.37-2.28 (m, 12H), 1.92-1.82
(m, 2H), 1.73-1.66 (m, 4H), 1.61-1.54 (m, 4H). 13C NMR (100
MHz, CDCl3): δ 152.8, 115.1, 68.0, 58.6, 54.1, 45.7, 27.1, 22.9.
HRMS-FAB for C22H38N4O2: calc 391.3073 [M + H]+, found
391.3085.
TABLE 2. Sh ifts, Sh ift Differ en ces (∆δ), a n d Sign a l
Br oa d en in g in 13C NMR of 9a
Ma cr ocycle 4. Compounds 1 (48 mg, 0.19 mmol) and 3 (75
mg, 0.19 mmol) and [Rh(acac)(CO)2] (4 mg, 16 µmol) were
mixed in 40 mL of toluene and stirred for 1 h. The solution
was placed in an autoclave, pressurized with 40 bar H2, and
heated at 50 °C for 18 h. The solvent was removed with a
rotary evaporator, and the crude product was purified by
column chromatography (silica gel, CH2Cl2/MeOH 95:5) to give
42 mg (36%) of 4 as a yellow viscous oil that solidifies upon
position and shift (ppm)
a
b
c
d
e
9
53.8
51.8 b
2.0
51.5 vb
2.3
58.4
57.6
0.8
23.5
22.4 b
0.9
27.5
26.9
0.6
68.9
68.6
0.3
68.6
0.3
9 + Zn2+
∆δ1
9 + 2Zn2+
∆δ2
57.8
0.6
22.3 b
1.2
26.7
0.8
1
standing. H NMR (400 MHz, CDCl3): δ 6.74 (s, 8H), 3.92 (t,
b ) broad, vb ) very broad; ∆δ1 ) (9 + 1 equiv of Zn2+) - 9;
∆δ2 ) (9 + 2 equiv of Zn2+) - 9.
a
J ) 6.0 Hz, 8H), 2.50-2.35 (m, 16H), 2.34 (t, J ) 7.3 Hz, 8H),
1.73-1.67 (m, 8H), 1.62-1.57 (m, 8H). 13C NMR (100 MHz,
CDCl3): δ 153.0, 115.6, 68.1, 57.8, 52.8, 27.1, 22.6. HRMS-
FAB for C36H56N4O4: calc 609.4380 [M + H]+, found 609.4402.
piperazine units. Upon complexation, part of the molecule
probably assumes a boat conformation where carbons in
position b and d are almost at the same distance from
Zn2+ while carbons between them are slightly closer.
Furthermore, upon addition of the second equivalent
of Zn2+ only slight additional downfield shifts are ob-
served, with an additional broadening of signals, which
indicates the formation of a 1:1 complex between the
macrocycle and Zn2+, with the cation inside the macro-
cyclic cavity.
3,5-Bis(4-oxo-bu toxy)-ben zoic Acid Meth yl Ester (6).
Compound 5 (226 mg, 0.91 mmol), [Rh(acac)(CO)2] (3 mg, 12
µmol), XANTPHOS (30 mg, 52 µmol), and toluene (15 mL)
were dissolved in the autoclave. The solution was pressurized
with 20 bar CO/H2 (1:1) and heated at 70 °C for 18 h. The
solvent was removed with a rotary evaporator, and the crude
mixture was purified by column chromatography (silica gel,
CH2Cl2) to give 200 mg (71%) of 6 as a colorless, viscous oil.
1H NMR (400 MHz, CDCl3): δ 9.76 (s, 2H), 7.07 (d, J ) 2.3
Hz, 2H), 6.52 (t, J ) 2.3 Hz, 1H), 3.94 (t, J ) 6.0 Hz, 4H), 3.62
(s, 3H), 2.59 (dt, J ) 5.8, 1.2 Hz, 4H), 2.08-2.01 (m, 4H). 13C
NMR (100 MHz, CDCl3): δ 201.6, 166.6, 159.6, 131.9, 107.7,
106.8, 66.9, 52.2, 40.4, 21.8. EA for C16H20O6 (308.33 g/mol):
calc C, 62.3; H, 6.5. Found: C, 62.4; H, 6.3. HRMS-FAB: calc
309.1338 [M + H]+, found 309.1346.
3,5-Bis[4-(4-ter t-bu tylca r boxy-p ip er a zin -1-yl)-bu toxy]-
ben zoic Acid Meth yl Ester (7). Following the procedure for
the synthesis of 2, starting from 6 and Boc-piperazine,
compound 7 was prepared in 72% yield as a colorless, viscous
oil.
3,5-Bis(4-p ip er a zin -1-yl-bu toxy)-ben zoic Acid Meth yl
Ester (8). Following the procedure for the synthesis of 3,
starting from 7, compound 8 was prepared in 89% yield as a
colorless, viscous oil.
Con clu sion
Azamacrocycles containing piperazine units are de-
signed as potential chemosensors for metal cations.
Complexation of cations was detected by fluorescence
spectroscopy and confirmed by NMR. Different sensitivi-
ties of macrocycles for different metals offer a variety of
applications of macrocycles in biological research. The
observed intramolecular charge transfer within noncon-
jugated macrocycles is an additional interesting property
of these compounds and is currently under further
investigation.
J . Org. Chem, Vol. 69, No. 16, 2004 5293